Jonelle C. Saunders focuses her practice on healthcare and litigation matters, as well as governmental and internal corporate investigations. Jonelle advises clients on general litigation strategy, regulatory enforcement, and compliance counseling. She also provides counsel to stakeholders across the healthcare industry including hospitals, health systems, large physician group practices, chain pharmacies, and global pharmaceutical and medical device manufacturers on US federal and state fraud and abuse matters and False Claims Act (FCA) actions.
Jonelle frequently writes and presents on electronic health record interoperability, blockchain distributed ledger technology, bioethics, and digital health innovation. She is a member of the Morgan Lewis Technology and Digital Health Initiatives.
Before joining Morgan Lewis, Jonelle was an associate at a large financial institution, where she served as in-house counsel focusing on litigation, government relations, government investigations, and regulatory enforcement. She continues to work on white collar issues and governmental and internal corporate investigations in various industries including financial services and healthcare. Jonelle has experience in investigations before the US Department of Justice, the HHS Office of Inspector General, the Consumer Financial Protection Bureau, and the Office of the Comptroller of Currency.
Jonelle received her J.D. from the University of Pennsylvania Law School, where she completed a joint degree in bioethics with the University of Pennsylvania Perelman School of Medicine. She worked as a senior researcher for the Leonard Institute of Health Economics focusing on interdisciplinary health system-related research and social and economic policy analysis.
Advised a global pharmaceutical company on unified response and legal strategy for a data breach incident response, including communications strategy and breach notification obligations.
Conducted an internal investigation for a large financial services company to assess risks related to fraudulent deposit and investment accounts.
Assessed Anti-Kickback and FCA risk for a specialty pharmacy in a government investigation of patient assistance programs.
Conducted independent compliance program assessments for a clinical research organization, a national pharmacy chain, and a hospital system.
Assisted a medical device company in structuring financial relationships and marketing practices to comply with transparency regulatory requirements.
Counseled a chain pharmacy on state and federal regulatory matters related to Medicare and Medicaid reimbursement and CMS budget proposals.
Assisted clients contemplating acquisitions in the healthcare sector with regulatory due diligence efforts.
Advised a national provider practice on compliance, billing, and reimbursement and operating under HHS Corporate Integrity Agreements.
Prepared advocacy commentary for an industry trade association on the requirements for hospice eligibility and Medicare requirements to influence federal healthcare policy.
University of Pennsylvania Law School, 2014, J.D.
University of Pennsylvania, School of Medicine, 2014, M.A., Bioethics
Carnegie Mellon University, 2011, B.S./M.S.
District of Columbia
Awards and Affiliations
Named, Modern Healthcare’s “Largest Healthcare Firm” (2016–2019)
Member, Health Law Section, American Bar Association
Member, American Health Lawyer's Association
Associate Editor, University of Pennsylvania Journal of Business Law